← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Definitive Healthcare Corp.: Revenue declined 4.2% to $242M from $252M. Net loss narrowed to $139M from $413M. Free cash flow declined 19.2% to $37.06M from $45.85M. Operating margin expanded 18899 bps to -92.86%. Definitive Healthcare Corp.'s annual comparison also shows margins improved while free cash flow declined; capital spending grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 4.2% to $242M from $252MWatch
- Profitability — Net loss narrowed to $139M from $413MOK
- Cash flow — Free cash flow declined 19.2% to $37.06M from $45.85MWatch
- Margins — Operating margin expanded 18899 bps to -92.86%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 0 purchases and 0 salesNote
Business
If the healthcare data market fails to grow, or grows more slowly than we currently anticipate, or if there is a decrease in the use of healthcare commercial intelligence, demand for our platform would be negatively affected.
Where the revenue comes from
Fiscal 2025, as Definitive Healthcare Corp. reports it. History and quarterly detail are in the app.
- Subscription Services$232.2M
- Professional Services$9.3M
Leadership changes
From Definitive Healthcare Corp.'s own filings, the day they're filed.
- Jeff Haywood · Directors · departureeff. 2026-03-30
- Jill Larsen · Directors · departureeff. 2025-07-21
- Kevin Coop · Chief Executive Officer · appointmenteff. 2024-06-24
Latest filings
- 8-K · Company announcement2026-09-02
- 8-K · Company announcement2026-09-02
- 8-K · Company announcement2026-08-10
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-06-24
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Definitive Healthcare Corp., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.